153 related articles for article (PubMed ID: 38664748)
1. Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial.
Zhang Y; Du H; Wang C; Huang X; Qu X; Wu R
Infect Agent Cancer; 2024 Apr; 19(1):16. PubMed ID: 38664748
[TBL] [Abstract][Full Text] [Related]
2. Application an internet facilitation in a community-based cervical cancer screening project.
Du H; Qu X; Wang G; Guo C; Wang Z; Min J; Liu Z; Hu Q; Luo H; Wang C; Huang X; Chen Y; Wu B; Belinson JL; Wu R
BMC Womens Health; 2023 Dec; 23(1):641. PubMed ID: 38041116
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
4. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
5. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of self-sampling-based cervical cancer screening strategy using HPV Selfy CE-IVD test coupled with home-collection kit: a clinical study in Italy.
Feltri G; Valenti G; Isidoro E; Kaur J; Treleani M; Bartelloni A; Mauro C; Spiga F; Ticich G; Di Napoli M; Biagi C; Pachetti M; Centonze S; Castriciano S; Zanchiello S; Giudici F; Gerin D; Zanconati F
Eur J Med Res; 2023 Dec; 28(1):582. PubMed ID: 38072937
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.
Arbyn M; Verdoodt F; Snijders PJ; Verhoef VM; Suonio E; Dillner L; Minozzi S; Bellisario C; Banzi R; Zhao FH; Hillemanns P; Anttila A
Lancet Oncol; 2014 Feb; 15(2):172-83. PubMed ID: 24433684
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cervical cancer through two HPV-based screen-and-treat implementation models in Malawi: protocol for a cluster randomized feasibility trial.
Tang JH; Smith JS; McGue S; Gadama L; Mwapasa V; Chipeta E; Chinkhumba J; Schouten E; Ngwira B; Barnabas R; Matoga M; Chagomerana M; Chinula L
Pilot Feasibility Stud; 2021 Apr; 7(1):98. PubMed ID: 33879259
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
Aarnio R; Östensson E; Olovsson M; Gustavsson I; Gyllensten U
BMC Cancer; 2020 Jul; 20(1):645. PubMed ID: 32660432
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and feasibility of self-sampling for human papillomavirus testing for internet-based cervical cancer screening.
Li J; Wu R; Qu X; Huang X; Li L; Lin Z; Zhang Z; Deng J; Liu R; Zhao X; Zhang S; Lin B; An R; Zhao C; Li M; Zhao Y; Wei L
Front Public Health; 2022; 10():938272. PubMed ID: 36420004
[TBL] [Abstract][Full Text] [Related]
14. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
16. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.
Polman NJ; Ebisch RMF; Heideman DAM; Melchers WJG; Bekkers RLM; Molijn AC; Meijer CJLM; Quint WGV; Snijders PJF; Massuger LFAG; van Kemenade FJ; Berkhof J
Lancet Oncol; 2019 Feb; 20(2):229-238. PubMed ID: 30658933
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
18. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
19. Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study.
Saville M; Hawkes D; Keung M; Ip E; Silvers J; Sultana F; Malloy MJ; Velentzis LS; Canfel L K; Wrede CD; Brotherton J
J Clin Virol; 2020 Jun; 127():104375. PubMed ID: 32361328
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]